EUVIMEDEUVIMED entdecken
Crossref

Protamine-derived peptide RPR (Arg-Pro-Arg) ameliorates oleic acid-induced lipogenesis via the PepT1 pathway in HepG2 cells

Maihemuti Mijiti, Ryosuke Mori, Yuga Nakashima, Arata Banno, Yuyang Ye, Asahi Takeuchi, Shoya Matsuba, Keisuke Kiriyama, Keita Sutoh iD, Satoshi Nagaoka iD

Bioscience, Biotechnology, and Biochemistry · 2023

DOI: 10.1093/bbb/zbac197 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioscience, Biotechnology, and Biochemistry, 2023. Verfasst von Maihemuti Mijiti und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Life Science, Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan. Hauptthemen laut MEDLINE: Lipogenesis, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, Fordays Co., Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The protamine-derived peptide arginine-proline-arginine (RPR) can ameliorate lifestyle-related diseases such as obesity and hypercholesterolemia. Thus, we hypothesized that the hypolipidemic activity of RPR could attenuate events leading to non-alcoholic fatty liver disease. Addition of 2 m m oleic acid (OA) to the culture medium induced fatty liver conditions in HepG2 cells. The OA + RPR group showed significantly decreased cellular or medium triglyceride (TG) level compared with the OA group. Stearoyl-CoA desaturase-1 (SCD1) or sterol regulatory element-binding protein 1 (SREBP1) protein level was significantly lower in the OA + RPR group than in the OA group. In the R + P + R amino acid mixture-treated group, the TG level was not significantly different from that in the OA-treated group. The OA + RP- or OA + PR-treated groups showed significantly decreased cellular TG level compared with the OA group. Moreover, the effect of RPR disappeared when the peptide transporter 1 (PepT1) was knocked down with a siRNA. Collectively, our results demonstrated that RPR effectively ameliorated hepatic steatosis in HepG2 cells via the PepT1 pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipogenesisNon-alcoholic Fatty Liver DiseaseHumansOleic AcidHep G2 CellsPeptide Transporter 1ProtaminesPeptidesProlineDipeptides

Stichwörter der Autor:innen

HepG2 cellsNAFLDPepT1RPRTG

Substanzen

Oleic AcidPeptide Transporter 1ProtaminesPeptidesProlinearginylprolineDipeptides

Autor:innen und Institutionen

  • Department of Applied Life Science, Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan.
  • Fordays Co., Ltd., Fordays Nutritional Research Center, 2-24-16 Nakacho, Koganei City, Tokyo, Japan.

ORCID-Profile: Keita Sutoh, Satoshi Nagaoka

Förderung

  • Ministry of Education, Culture, Sports, Science and Technology
  • Fordays Co., Ltd.

Zitieren

APA

Mijiti, M., Mori, R., Nakashima, Y., Banno, A., Ye, Y., Takeuchi, A., Matsuba, S., Kiriyama, K., Sutoh, K., & Nagaoka, S. (2023). Protamine-derived peptide RPR (Arg-Pro-Arg) ameliorates oleic acid-induced lipogenesis via the PepT1 pathway in HepG2 cells. Bioscience, Biotechnology, and Biochemistry. https://doi.org/10.1093/bbb/zbac197

Vancouver

Mijiti M, Mori R, Nakashima Y, Banno A, Ye Y, Takeuchi A, et al. Protamine-derived peptide RPR (Arg-Pro-Arg) ameliorates oleic acid-induced lipogenesis via the PepT1 pathway in HepG2 cells. Bioscience, Biotechnology, and Biochemistry. 2023. doi:10.1093/bbb/zbac197

BibTeX
@article{Mijiti2023,
  author = {Mijiti, Maihemuti and Mori, Ryosuke and Nakashima, Yuga and Banno, Arata and Ye, Yuyang and Takeuchi, Asahi and Matsuba, Shoya and Kiriyama, Keisuke and Sutoh, Keita and Nagaoka, Satoshi},
  title = {Protamine-derived peptide RPR (Arg-Pro-Arg) ameliorates oleic acid-induced lipogenesis via the PepT1 pathway in HepG2 cells},
  journal = {Bioscience, Biotechnology, and Biochemistry},
  year = {2023},
  doi = {10.1093/bbb/zbac197}
}
Kostenlos starten →